AMERICAN CANCER SOCIETY JOINS SCREENING SUPPORTERSWASHINGTON, Jan. 11, 2013 /PRNewswire-USNewswire/ -- Today, in response to the announcement by the American Cancer Society, Lung Cancer Alliance (LCA) President & CEO Laurie Fenton Ambrose said: "We are pleased that the American Cancer Society has joined Lung Cancer Alliance, other leading professional organizations and medical centers around the country in endorsing CT screening for those at high risk for lung cancer." "No one disputes the results of the National Lung Screening Trial; screening works," she said, referring to the large randomized controlled trial (NLST) launched by the National Cancer Institute in 2002 and terminated in 2010. "The issues are how to deploy lung cancer screening responsibly and equitably, and how to determine who else will benefit beyond the NLST population of older, heavy smokers. We are addressing these issues through our National Framework for Excellence in Lung Screening and Continuum of Care," Fenton Ambrose explained. The National Framework, launched by LCA early last year, outlines the rights of the at-risk public, guiding principles for screening sites and also calls for collection of data on outcomes so that lung cancer screening can be continuously improved through a rapid learning process. "This is important because we have already seen improvements in imaging and protocols since the screening rounds in the NLST were completed," said James Mulshine, MD, LCA Board member and Associate Provost for Research at Rush University. "This is critical. 160,000 people a year are dying of lung cancer and that is close to a third of all cancer deaths in the United States," he said. Over the past two years, in addition to LCA, the National Comprehensive Cancer Network (NCCN), American Association of Thoracic Surgeons (AATS), and others have publicly supported screening those at risk.